Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics

New trends in guided nanotherapies for digestive cancers: A systematic review

(2015) Elisabete Fernandes et al.   JOURNAL OF CONTROLLED RELEASE

Significance of 4E-binding protein 1 as a therapeutic target for invasive urothelial carcinoma of the bladder

(2015) Masatomo Nishikawa et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

518 Patient-derived sialyl-Tn positive invasive bladder cancer xenografts in nude mice: An exploratory model study

(2014) J.A. Ferreira et al.   EUROPEAN UROLOGY SUPPLEMENTS

Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells

(2014) Mylène A. Carrascal et al.   Molecular Oncology

Modification of sialylation is associated with multidrug resistance in human acute myeloid leukemia

(2014) H Ma et al.   ONCOGENE

Targeting PI3K/Akt/mTOR Signaling in Cancer

(2014) Camillo Porta et al.   Frontiers in Oncology

Response of high-risk of recurrence/progression bladder tumours expressing sialyl-Tn and sialyl-6-T to BCG immunotherapy

(2013) L Lima et al.   BRITISH JOURNAL OF CANCER

EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013

(2013) Marko Babjuk et al.   EUROPEAN UROLOGY

Dysregulation of mammalian target of rapamycin pathway in upper tract urothelial carcinoma

(2013) Enrico Munari et al.   HUMAN PATHOLOGY

Relevance of the mammalian target of rapamycin pathway in the prognosis of patients with high-risk non–muscle invasive bladder cancer

(2013) Mona Fahmy et al.   HUMAN PATHOLOGY

PI3K/AKT pathway activation in bladder carcinogenesis

(2013) Julien Calderaro et al.   INTERNATIONAL JOURNAL OF CANCER

Overexpression of tumour-ssociated carbohydrate antigen sialyl-Tn in advanced bladder tumours

(2013) José Alexandre Ferreira et al.   Molecular Oncology

A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma

(2012) Penelope Korkolopoulou et al.   BJU INTERNATIONAL

Everolimus Enhances Gemcitabine-Induced Cytotoxicity in Bladder-Cancer Cell Lines

(2012) Rosário Pinto-Leite et al.   JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES

High Levels of Phosphatase and Tensin Homolog Expression Are Associated With Tumor Progression, Tumor Recurrence, and Systemic Metastases in pT1 Urothelial Carcinoma of the Bladder: A Tissue Microarray Study of 156 Patients Treated by Transurethral Resection

(2012) Alcides Chaux et al.   UROLOGY

Mechanisms of cancer-associated glycosylation changes

(2011) Fabio Dall'Olio   Frontiers in Bioscience-Landmark

Activation of the PI3K/Akt/mTOR pathway correlates with tumour progression and reduced survival in patients with urothelial carcinoma of the urinary bladder

(2011) Chih-Hao Sun et al.   HISTOPATHOLOGY

Expanding therapeutic targets in bladder cancer: the PI3K/Akt/mTOR pathway

(2010) Christina Barbara Ching et al.   LABORATORY INVESTIGATION

Biological similarities between murine chemical-induced and natural human bladder carcinogenesis

(2010) CARLOS PALMEIRA et al.   Oncology Letters

Emerging targeted therapies for bladder cancer: a disease waiting for a drug

(2009) Simon J. Dovedi et al.   CANCER AND METASTASIS REVIEWS

Analysis of the expression of biomarkers in urinary bladder cancer using a tissue microarray

(2008) Loleta D. Harris et al.   MOLECULAR CARCINOGENESIS

The role of PTEN signaling perturbations in cancer and in targeted therapy

(2008) M Keniry et al.   ONCOGENE